180 Capital Stock from 2010 to 2025

ATNF Stock  USD 1.17  0.01  0.85%   
180 Life's Capital Stock is decreasing over the last several years with slightly volatile swings. Capital Stock is predicted to flatten to 46.17. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals
 
Capital Stock  
First Reported
2010-12-31
Previous Quarter
48.6
Current Value
46.17
Quarterly Volatility
885.7133333
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check 180 Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 180 Life's main balance sheet or income statement drivers, such as Interest Expense of 48.98, Selling General Administrative of 6.4 M or Interest Income of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. 180 financial statements analysis is a perfect complement when working with 180 Life Valuation or Volatility modules.
  
Check out the analysis of 180 Life Correlation against competitors.

Latest 180 Life's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of 180 Life Sciences over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. 180 Life's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 180 Life's overall financial position and show how it may be relating to other accounts over time.
Capital Stock10 Years Trend
Slightly volatile
   Capital Stock   
       Timeline  

180 Capital Stock Regression Statistics

Arithmetic Mean1,274
Geometric Mean751.90
Coefficient Of Variation69.52
Mean Deviation571.55
Median1,384
Standard Deviation885.71
Sample Variance784,488
Range3.4K
R-Value(0.32)
Mean Square Error752,950
R-Squared0.10
Significance0.22
Slope(60.05)
Total Sum of Squares11.8M

180 Capital Stock History

2025 46.17
2024 48.6
2023 54.0
2022 375.0
2021 3404.0
2020 2617.0

Other Fundumenentals of 180 Life Sciences

180 Life Capital Stock component correlations

0.450.140.640.40.110.870.850.02-0.03-0.060.150.170.040.28-0.210.260.180.37-0.280.280.190.27
0.45-0.170.480.850.520.63-0.08-0.05-0.560.350.580.670.570.23-0.210.190.00.63-0.310.270.00.21
0.14-0.17-0.65-0.47-0.72-0.130.30.370.9-0.89-0.37-0.57-0.870.9-0.580.920.940.47-0.70.850.950.91
0.640.48-0.650.660.570.790.39-0.14-0.730.630.460.540.73-0.480.35-0.51-0.55-0.110.3-0.45-0.55-0.48
0.40.85-0.470.660.70.65-0.1-0.16-0.760.450.740.90.73-0.090.11-0.18-0.260.46-0.18-0.09-0.32-0.09
0.110.52-0.720.570.70.2-0.23-0.77-0.760.710.260.830.75-0.480.22-0.46-0.720.150.42-0.33-0.72-0.5
0.870.63-0.130.790.650.20.590.22-0.390.170.570.420.370.07-0.050.020.060.25-0.240.070.030.07
0.85-0.080.30.39-0.1-0.230.590.080.34-0.29-0.22-0.25-0.320.22-0.150.230.240.05-0.130.20.250.22
0.02-0.050.37-0.14-0.16-0.770.220.080.21-0.380.36-0.4-0.210.32-0.020.230.56-0.09-0.510.120.530.34
-0.03-0.560.9-0.73-0.76-0.76-0.390.340.21-0.86-0.64-0.76-0.970.65-0.450.70.730.15-0.40.610.760.66
-0.060.35-0.890.630.450.710.17-0.29-0.38-0.860.190.460.83-0.750.5-0.73-0.86-0.370.72-0.7-0.87-0.75
0.150.58-0.370.460.740.260.57-0.220.36-0.640.190.680.62-0.130.1-0.24-0.050.16-0.28-0.13-0.09-0.13
0.170.67-0.570.540.90.830.42-0.25-0.4-0.760.460.680.71-0.280.14-0.32-0.390.320.03-0.16-0.45-0.29
0.040.57-0.870.730.730.750.37-0.32-0.21-0.970.830.620.71-0.620.44-0.66-0.74-0.120.38-0.57-0.72-0.63
0.280.230.9-0.48-0.09-0.480.070.220.320.65-0.75-0.13-0.28-0.62-0.650.980.90.78-0.870.920.921.0
-0.21-0.21-0.580.350.110.22-0.05-0.15-0.02-0.450.50.10.140.44-0.65-0.71-0.59-0.530.46-0.77-0.64-0.6
0.260.190.92-0.51-0.18-0.460.020.230.230.7-0.73-0.24-0.32-0.660.98-0.710.890.73-0.760.960.910.97
0.180.00.94-0.55-0.26-0.720.060.240.560.73-0.86-0.05-0.39-0.740.9-0.590.890.5-0.820.840.980.91
0.370.630.47-0.110.460.150.250.05-0.090.15-0.370.160.32-0.120.78-0.530.730.5-0.770.740.510.76
-0.28-0.31-0.70.3-0.180.42-0.24-0.13-0.51-0.40.72-0.280.030.38-0.870.46-0.76-0.82-0.77-0.71-0.8-0.87
0.280.270.85-0.45-0.09-0.330.070.20.120.61-0.7-0.13-0.16-0.570.92-0.770.960.840.74-0.710.880.9
0.190.00.95-0.55-0.32-0.720.030.250.530.76-0.87-0.09-0.45-0.720.92-0.640.910.980.51-0.80.880.91
0.270.210.91-0.48-0.09-0.50.070.220.340.66-0.75-0.13-0.29-0.631.0-0.60.970.910.76-0.870.90.91
Click cells to compare fundamentals

About 180 Life Financial Statements

180 Life stakeholders use historical fundamental indicators, such as 180 Life's Capital Stock, to determine how well the company is positioned to perform in the future. Although 180 Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in 180 Life's assets and liabilities are reflected in the revenues and expenses on 180 Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 180 Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Stock 48.60  46.17 
Issuance Of Capital Stock21.3 M13 M

Currently Active Assets on Macroaxis

When determining whether 180 Life Sciences is a strong investment it is important to analyze 180 Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 180 Life's future performance. For an informed investment choice regarding 180 Stock, refer to the following important reports:
Check out the analysis of 180 Life Correlation against competitors.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
7.98
Return On Assets
(0.52)
Return On Equity
(1.74)
The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.